ARTICLE | Company News
Broad Institute, Takara Bio deal
November 24, 2014 8:00 AM UTC
Takara’s Clontech Laboratories Inc. subsidiary received non-exclusive rights to Broad’s IP related to CRISPR/ Cas9 gene editing system. CRISPR systems use small guide RNAs that pair with a target DNA...